This was the stock's third consecutive day of gains.
Both of these metrics are at their most attractive levels in the company's history, making this a once-in-a-decade ...
Greenwich Academy's 2025 commencement speaker is Kristin Coveny Peck, the CEO of Zoetis, an animal health company.
TUESDAY, Feb. 18, 2025 (HealthDay News) -- The U.S. Department of Agriculture (USDA) has granted conditional approval for a ...
Zoetis' Q4 earnings met expectations, but the stock fell due to slowing growth and cautious 2025 guidance. Click here to find ...
Zoetis slightly topped analyst estimates for profitability and met those for revenue in its fourth quarter. But as investors ...
A New Jersey pharmaceutical company has received a “a conditional license" for its bird flu vaccine for use in chickens. An ...
Zoetis exceeded market expectations in Q4 2024, with impressive financial performance despite challenges in specific segments ...
BTIG lowered the firm’s price target on Zoetis (ZTS) to $200 from $225 and keeps a Buy rating on the shares. The company delivered an in-line ...
Phibro Animal Health projects strong 2025 revenue growth despite debt concerns. Read this artile to know why I think PAHC ...
Roxanne Lagano, Executive Vice President at Zoetis Inc . (NYSE:ZTS), recently executed a sale of company stock. According to a recent SEC filing, Lagano sold 326 shares of Zoetis common stock at a ...
Q4 2024 Earnings Call Feb 13, 2025, 8:30 a.m. ET. Contents: Prepared Remarks. Questions and Answers. Call Participants.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results